COSCIENS Biopharma Inc. Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019
COSCIENS Biopharma Inc. (CSCIF) reported Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019 of 13.83 CAD/shares for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-25.
Financial Statements › Notes › Compensation Related Costs
ifrs-full:WeightedAverageExercisePriceOfShareOptionsForfeitedInSharebasedPaymentArrangement2019 · last filed 2026-03-25
- COSCIENS Biopharma Inc. weighted average exercise price of share options forfeited in share-based payment arrangement2019 for the quarter ending 2025-03-31 was $14.42, a 19.47% increase year-over-year.
- COSCIENS Biopharma Inc. weighted average exercise price of share options forfeited in share-based payment arrangement2019 for the quarter ending 2024-03-31 was $12.07.
- COSCIENS Biopharma Inc. weighted average exercise price of share options forfeited in share-based payment arrangement2019 for the quarter ending 2022-03-31 was $10.98.
USD/shares
| Period end | Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019 3 month | Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019 3 month as first filed | Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019 6 month | Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019 9 month | Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019 9 month as first filed | Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019 12 month | Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2025-09-30 | $13.83 6-K · filed 2025-11-12 | ||||||
| 2025-03-31 | $14.42 6-K · filed 2025-08-14 | $15.92 6-K · filed 2025-05-13 | |||||
| 2024-12-31 | $25.71 20-F · filed 2025-04-09 | ||||||
| 2024-09-30 | $34.90 6-K · filed 2025-11-12 | ||||||
| 2024-06-30 | $12.07 6-K · filed 2025-08-14 | ||||||
| 2024-03-31 | $12.07 6-K · filed 2025-05-13 | $42.04 6-K · filed 2024-05-16 | |||||
| 2023-12-31 | $25.00 20-F · filed 2025-04-09 | ||||||
| 2023-09-30 | $19.06 6-K · filed 2024-11-12 | $87.00 6-K · filed 2023-11-09 | |||||
| 2023-06-30 | $19.00 6-K · filed 2024-08-13 | ||||||
| 2022-12-31 | $27.12 20-F · filed 2025-04-09 | $14.00 20-F · filed 2023-03-23 | |||||
| 2022-09-30 | $10.98 6-K · filed 2023-11-09 | ||||||
| 2022-06-30 | $10.98 6-K · filed 2023-08-09 | ||||||
| 2022-03-31 | $10.98 6-K · filed 2023-05-09 | ||||||
| 2020-12-31 | $64.00 20-F/A · filed 2024-02-15 |
CAD/shares
| Period end | Weighted Average Exercise Price Of Share Options Forfeited In Share-based Payment Arrangement2019 12 month |
|---|---|
| 2025-12-31 | 13.83 CAD/shares 20-F · filed 2026-03-25 |
| 2024-12-31 | 25.71 CAD/shares 20-F · filed 2026-03-25 |
| 2023-12-31 | 25.00 CAD/shares 20-F · filed 2026-03-25 |